These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28157499)

  • 1. The Temporal Ordering of Cell-Cycle Phosphorylation.
    Kamenz J; Ferrell JE
    Mol Cell; 2017 Feb; 65(3):371-373. PubMed ID: 28157499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative model for ordered Cdk substrate dephosphorylation during mitotic exit.
    Bouchoux C; Uhlmann F
    Cell; 2011 Nov; 147(4):803-14. PubMed ID: 22078879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal control of the dephosphorylation of Cdk substrates by mitotic exit pathways in budding yeast.
    Jin F; Liu H; Liang F; Rizkallah R; Hurt MM; Wang Y
    Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16177-82. PubMed ID: 18845678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Themes and variations: the first Salk Institute Cell Cycle Meeting, 18-22 June 1999.
    Forsburg SL
    Biochim Biophys Acta; 2000 Feb; 1470(1):R13-6. PubMed ID: 10656990
    [No Abstract]   [Full Text] [Related]  

  • 6. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
    Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
    EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple levels of cyclin specificity in cell-cycle control.
    Bloom J; Cross FR
    Nat Rev Mol Cell Biol; 2007 Feb; 8(2):149-60. PubMed ID: 17245415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G1-phase and B-type cyclins exclude the DNA-replication factor Mcm4 from the nucleus.
    Labib K; Diffley JF; Kearsey SE
    Nat Cell Biol; 1999 Nov; 1(7):415-22. PubMed ID: 10559985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
    Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R
    Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TgI4 lipase: a big fat target for cell-cycle entry.
    Futcher B
    Mol Cell; 2009 Jan; 33(2):143-4. PubMed ID: 19187756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclins in a dinoflagellate cell cycle.
    Leveson A; Wong F; Wong JT
    Mol Mar Biol Biotechnol; 1997 Sep; 6(3):172-9. PubMed ID: 9284557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells.
    Van Dross R; Yao S; Asad S; Westlake G; Mays DJ; Barquero L; Duell S; Pietenpol JA; Browning PJ
    J Natl Cancer Inst; 2005 May; 97(9):656-66. PubMed ID: 15870436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclins and the G2/M transition.
    Jackman MR; Pines JN
    Cancer Surv; 1997; 29():47-73. PubMed ID: 9338096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PP2A
    Godfrey M; Touati SA; Kataria M; Jones A; Snijders AP; Uhlmann F
    Mol Cell; 2017 Feb; 65(3):393-402.e3. PubMed ID: 28132839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.